The risk of suicide attempt is highest in the first 30 days following ideation diagnosis and is more common among women, combat medics, and soldiers with an anxiety disorder diagnosis prior to suicidal ideation and a same-day sleep disorder diagnosis, suggests a US study of army soldiers.
Girls who have been exposed to abuse have a delayed structural maturation pattern specific to emotion circuitry, which is potentially an adaptive mechanism that enhances threat generalization, a study has found. On the other hand, physical neglect correlates with a broader brain-wide pattern of advanced structural maturation.
Thirty-day readmissions are similar between patients who had at least one psychotropic medication upon discharge and those who had none, reports a study. However, the former has a higher number of discrepancies that require significantly more discharge interventions during a pharmacist-driven discharge medication reconciliation (DMR).
A primary care-based cognitive behavioural therapy (CBT) delivered by frontline clinicians results in modest but sustained reductions in pain and pain-related disability relative to usual care, reports a study. However, the intervention does not appear to reduce the use of opioid medication.
Among individuals living with depression and anxiety, the use of electronic wearable devices (EWDs) might be an indicator of their intent to lose weight and in turn may be valuable as a starting point for clinical interactions aimed at improving physical health, according to a recent study.
During Singapore’s coronavirus disease 2019 (COVID-19) lockdown, older adults experienced a decrease in depressive symptoms accompanied by growing feelings of loneliness and lower physical activity (PA), according to a recent study.
By using digital biomarkers that reflect behavioural and physiological patterns, consumer-grade wearable devices have the potential to screen for people with or at risk of depression, according to a recent Singapore study.
Results of a randomized, double-blind, placebo-controlled trial show no benefit with mirtazapine, given with normal clinical care, for treatment of clinically significant agitation in patients with dementia compared with placebo, with a potentially higher mortality observed with the use of mirtazapine.